Cargando…
Corrigendum to ‘Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells’[Redox Biol 6(2015):174–182]
Autores principales: | Rodríguez-Hernández, A., Navarro-Villarán, E., González, R., Pereira, S., Soriano-De Castro, L.B., Sarrias-Giménez, A., Barrera-Pulido, L., Álamo-Martínez, J.M., Serrablo-Requejo, A., Blanco-Fernández, G., Nogales-Muñoz, A., Gila-Bohórquez, A., Pacheco, D., Torres-Nieto, M.A., Serrano-Díaz-Canedo, J., Suárez-Artacho, G., Bernal-Bellido, C., Marín-Gómez, L.M., Barcena, J.A., Gómez-Bravo, M.A., Padilla, C.A., Padillo, F.J., Muntané, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257207/ https://www.ncbi.nlm.nih.gov/pubmed/37246098 http://dx.doi.org/10.1016/j.redox.2023.102744 |
Ejemplares similares
-
Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells()
por: Rodríguez-Hernández, A., et al.
Publicado: (2015) -
Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in NOS-3 overexpressing hepatoblastoma cells
por: González, Raúl, et al.
Publicado: (2015) -
Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies
por: Navarro-Villarán, Elena, et al.
Publicado: (2016) -
Corrigendum to “Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer” [Redox Biol. 34 (2020) 101528]
por: González, R., et al.
Publicado: (2023) -
Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells
por: Rodríguez-Hernández, María A., et al.
Publicado: (2020)